Growth Metrics

Evaxion A (EVAX) Change in Intangibles (2020 - 2021)

Evaxion A filings provide 2 years of Change in Intangibles readings, the most recent being -$60000.0 for Q3 2021.

  • Change in Intangibles hit -$60000.0 in Q3 2021 for Evaxion A, roughly flat from -$60000.0 in the prior quarter.
  • Across five years, Change in Intangibles topped out at -$35000.0 in Q2 2020 and bottomed at -$60000.0 in Q1 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Intangibles (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - 68,980.00
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn -
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 605.66 Bn 605.66 Bn - -
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn -
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn -
8 Evaxion A 65.12 Bn 65.10 Bn - -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn -
10 Revolution Medicines 30.42 Bn 30.42 Bn - -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2021 -60,000.00
Sep 30, 2021 -60,000.00
Jun 30, 2021 -60,000.00
Jun 30, 2021 -60,000.00
Mar 31, 2021 -60,000.00
Mar 31, 2021 -60,000.00
Sep 30, 2020 -35,000.00
Sep 30, 2020 -35,000.00
Jun 30, 2020 -35,000.00
Jun 30, 2020 -35,000.00